During the past decade, Ege University Medical Faculty conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 33 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 23 clinical trials were completed. i.e. 43.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ege University Medical Faculty" #1 sponsor was "Ege University" with 18 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Pfizer" with 11 trials sponsored and "Celgene" with 11 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ege University Medical Faculty" #1 collaborator was "Takeda Development Center Americas, Inc." with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Ege University Medical Faculty" are "Breast Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Crohn Disease" (4 trials), "Hemophilia A" (4 trials) and "Hemophilia B" (4 trials). Many other conditions were trialed in "Ege University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Ege University Medical Faculty" are "Drug" (79 trials), "Biological" (15 trials), "Other" (13 trials), "Device" (4 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Dexamethasone" (4 trials), "Abemaciclib" (3 trials), "Avelumab" (3 trials) and "Bortezomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ege University Medical Faculty" are 114 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ege University Medical Faculty". undefined are not yet recruiting, 27 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Ege University Medical Faculty, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Ege University Medical Faculty, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".